Advertisement

Picture Campus Berlin-Buch GmbH BBC BerlinBioCube Start-up Center 650x100px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in France and Monaco or involving organisations from these countries.

Total search results: 2099 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Catalym–Jeito Capital: investment, 202211 financing round Series C totalling €50m incl new + co-lead investor Jeito Capital 2022-11-22
Catalym–SEVERAL: investment, 202211 financing round Series C €50m led by Brandon Capital + Jeito Capital 2022-11-22
Cradle Bio–PERSON: investment, 202211 seed financing round totalling €5.5m incl angel investor Sylvain Gariel 2022-11-17
Sarcura–SEVERAL: investment, 202211 seed plus financing round €7m co-led by Lansdowne Investment Co Cyprus + IST Cube 2022-11-17
BC Platforms–Jolt Capital: investment, 202211 growth financing round totalling CHF20m incl new + lead investor Jolt Capital 2022-11-08
BC Platforms–SEVERAL: investment, 202211 growth financing round CHF20m led by new investor Jolt Capital 2022-11-08
Normunity–SEVERAL: investment, 202210 financing round Series A $65m led by Canaan Ventures + company launch announced 2022-10-25
Aqemia–SEVERAL: investment, 202210 financing round Series A €30m led by Eurazeo + Bpifrance Large Venture Fund 2022-10-19
Univercells–SEVERAL: investment, 202210 financing round Series D 1st closing €44m with SFPI-FPIM + SRIW et al 2022-10-19
MS-Omics–Clinical Microbiomics: investment, 202210 acquisition of MS-Omics ApS by Clinical Microbiomics A/S 2022-10-17
Mablink Bioscience–Crédit Agricole: investment, 202210 financing round Series A totalling €31m incl existing + co-investor Crédit Agricole Création 2022-10-14
Mablink Bioscience–Elaia Partners: investment, 202210 financing round Series A totalling €31m incl existing + co-investor Elaia Partners 2022-10-14
Mablink Bioscience–Fournier-Majoie Foundation: investment, 202210 financing round Series A totalling €31m incl existing + co-investor Fondation FM 2022-10-14
Mablink Bioscience–Mérieux: investment, 202210 financing round Series A totalling €31m incl new + co-lead investor Mérieux Equity Partners 2022-10-14
Mablink Bioscience–Pertinence Invest 2: investment, 202210 financing round Series A totalling €31m incl existing + co-investor Pertinence Invest 2 2022-10-14
Mablink Bioscience–SEVERAL: investment, 202210 financing round Series A €31m led by Sofinnova Partners + Mérieux Equity Partners 2022-10-14
Mablink Bioscience–Sham: investment, 202210 financing round Series A totalling €31m incl existing + co-investor Sham Innovation Santé 2022-10-14
Mablink Bioscience–Simba Santé: investment, 202210 financing round Series A totalling €31m incl existing + co-investor Simba Santé 2022-10-14
Mablink Bioscience–Sofinnova: investment, 202210 financing round Series A totalling €31m incl new + co-lead investor Sofinnova Partners 2022-10-14
Clinical Microbiomics–BPCE: investment, 202210 investment €10m from Health for Life Capital II fund managed by Seventure Partners 2022-10-11
Andera Partners–SEVERAL: investment, 202210 final closing of BioDiscovery 6 fund at €456m 2022-10-10
Cevec–Danaher: investment, 202210 acquisition of Cevec by Cytiva 2022-10-06
Matchpoint Therapeutics–Sanofi: investment, 202210c financing round Series A totalling $70m incl new + lead investor Sanofi Ventures 2022-10-01
Valneva–SEVERAL: investment, 202209–202210 private placement €100-45m of 20.5m ordinary shares at €4.9/share 2022-09-28
Valneva–SEVERAL: investment, 202209–202210 public offering $3.57m of 375k ADSs (each = 2 ordinary shares) at $9.51/ADS 2022-09-28
EFOS (SI)–Demeter: investment, 202209 financing round Series B totalling €10m incl co-investor VitiRey Innovation fund 2022-09-20
EFOS (SI)–Pymwymic: investment, 202209 financing round Series B totalling €10m incl existing + co-investor Pymwymic 2022-09-20
EFOS (SI)–SEVERAL: investment, 202209 financing round Series B €10m led by ECBF 2022-09-20
Flash Therapeutics–Techlife Capital: investment, 202209 existent investment of Techlife Capital 2022-09-20
Mitem Pharma–Techlife Capital: investment, 202209 existent investment of Techlife Capital 2022-09-20
MyData Trust–Techlife Capital: investment, 202209 existent investment of Techlife Capital 2022-09-20
Quinten–MACSF: investment, 202209 financing round totalling €14m incl investor MACSF 2022-09-20
Quinten–SEVERAL: investment, 202209 financing round €14m growth equity investment for Quinten Health from Techlife Capital + MACSF 2022-09-20
Quinten–Techlife Capital: investment, 202209 financing round totalling €14m incl investor Techlife Capital 2022-09-20
XPath–Techlife Capital: investment, 202209 existent investment of Techlife Capital 2022-09-20
Versantis–Genfit: investment, 202209– acquisition CHF40m upfront + CHF65m milestones + 1/3 of net proceeds of eventual PRV 2022-09-19
SparingVision–SEVERAL: investment, 202209 financing round Series B €75m led by Jeito Capital + UPMC Enterprises 2022-09-15
Tridek-One–AdBio Partners: investment, 202209 2nd financing round totalling €16m incl existing + co-investor AdBio Partners 2022-09-15
Tridek-One–Advent Life Sciences: investment, 202209 2nd financing round totalling €16m incl existing + co-investor Advent Life Sciences 2022-09-15
Tridek-One–Bellevue: investment, 202209 2nd financing round totalling €16m incl new + lead investor Pureos Bioventures 2022-09-15
Tridek-One–Bioqube Ventures: investment, 202209 2nd financing round totalling €16m incl new + co-investor Bioqube Ventures 2022-09-15
Tridek-One–France (govt): investment, 202209 2nd financing round totalling €16m incl new + co-investor Bpifrance via InnoBio 2 Fund 2022-09-15
Tridek-One–SEVERAL: investment, 202209 2nd financing round €16m led by Pureos Bioventures 2022-09-15
Standing Ovation–Astanor Ventures: investment, 202209 financing round Series A totalling €12m incl lead investor Astanor Ventures 2022-09-14
Standing Ovation–SEVERAL: investment, 202209 financing round Series A €12m lead by Astanor Ventures 2022-09-14
Aido–NLC Ventures: investment, 202209 existent seed investor NLC 2022-09-08
Abivax–Column Group: investment, 202209 reserved equity capital increase totalling €46.2m incl new + lead investor TCG X 2022-09-02
Abivax–Deep Track Capital: investment, 202209 reserved equity capital increase totalling €46.2m incl new + co-investor Deep Track Capital 2022-09-02
Abivax–Invus Group: investment, 202209 reserved equity capital increase totalling €46.2m incl co-investor Invus 2022-09-02
Abivax–Rockefeller: investment, 202209 reserved equity capital increase totalling €46.2m incl new + co-investor Venrock Healthcare Capital Partners 2022-09-02
Abivax–Santé Holding: investment, 202209 reserved equity capital increase totalling €46.2m incl €0.8m from existing + co-investor Santé Holding 2022-09-02
Abivax–SEVERAL: investment, 202209 issuance of royalty certificates for €2.9m 2022-09-02
Abivax–SEVERAL: investment, 202209 reserved equity capital increase €46.2m with 5.53m new shares at €8.36/share led by TCG X 2022-09-02
Abivax–Sofinnova: investment, 202209 reserved equity capital increase totalling €46.2m incl €4.9m from existing + co-investor Sofinnova Partners 2022-09-02
Abivax–Truffle Capital: investment, 202209 reserved equity capital increase totalling €46.2m incl €1.6m from existing + co-investor Truffle Capital 2022-09-02
Genome Diagnostics–Eurobio Scientific: investment, 202208– acquisition 100% of GenDx for €135m in cash (net of adjusted cash) 2022-08-17
Albumedix–Sartorius: investment, 202208– acquisition £415m 100% of Albumedix by Sartorius Stedim Biotech ANNOUNCED 2022-08-08
F2G Ltd–Novo Group: investment, 202208 financing round totalling $70m inc existing + co-investor Novo Holdings 2022-08-04
F2G Ltd–SEVERAL: investment, 202208 financing round $70m co-led by new investors Forbion + Sofinnova Partners 2022-08-04
F2G Ltd–Sofinnova: investment, 202208 financing round totalling $70m inc new + co-lead investor Sofinnova Partners 2022-08-04
Forty51 Ventures–Fischli Group: investment, 202207 first closing totalling $43m of Forty51 Ventures I fund incl co-lead investor Fischli Family 2022-07-18
Forty51 Ventures–OTHER: investment, 202207 first closing totalling $43m of Forty51 Ventures I fund incl biotech entrepreneures + private individuals 2022-07-18
Forty51 Ventures–SEVERAL: investment, 202207 first $43m closing of Forty51 Ventures I fund 2022-07-18
Forty51 Ventures–Stable Asset Management: investment, 202207 first closing totalling $43m of Forty51 Ventures I fund incl co-lead investor SAM 2022-07-18
Agomab Therapeutics–OTHER: investment, 202207 financing round Series B extension totalling $40.5m incl existing-investors 2022-07-13
Agomab Therapeutics–SEVERAL: investment, 202207 financing round Series B extension $40.5m led by Pfizer bringing total Series B to $114m 2022-07-13
Biosyntia–ECBF: investment, 202207 financing round Series B totalling €11.5m incl new + lead investor ECBF 2022-07-07
Biosyntia–Novo Group: investment, 202207 financing round Series B totalling €11.5m incl existing + co-investor Novo Seeds 2022-07-07
Biosyntia–SEVERAL: investment, 202207 financing round Series B €11.5m led by new investor ECBF 2022-07-07
Biosyntia–Sofinnova: investment, 202207 financing round Series B totalling €11.5m incl existing + co-investor Sofinnova Partners 2022-07-07
Ganymed Robotics–BNP Paribas: investment, 202207 financing round Series B first closing totalling €21m incl co-investor BNP Paribas Développement 2022-07-07
Ganymed Robotics–Cathay Capital: investment, 202207 financing round Series B first closing totalling €21m incl lead investor Cathay Health 2022-07-07
Ganymed Robotics–Crédit Mutuel-CIC: investment, 202207 financing round Series B first closing totalling €21m incl co-investor Crédit Mutuel Innovation 2022-07-07
Ganymed Robotics–Eurazeo: investment, 202207 financing round Series B first closing totalling €21m incl co-investor Kurma Partners 2022-07-07
Ganymed Robotics–OTHER: investment, 202207 financing round Series B first closing totalling €21m incl internationallly renowned surgeons 2022-07-07
Ganymed Robotics–SEVERAL: investment, 202207 financing round Series B first closing €21m led by Cathay Health 2022-07-07
Aurobac Therapeutics–Boehringer: investment, 202207 launch of €40m joint venture Aurobac incl €30m from lead investor Boehringer Ingelheim 2022-07-06
Boehringer–Evotec: investment, 202207 launch of €40m joint venture Aurobac incl €5m from co-investor Evotec 2022-07-06
Boehringer–Mérieux: investment, 202207 launch of €40m joint venture Aurobac incl €5m from co-investor bioMérieux 2022-07-06
Epizyme–Ipsen: investment, 202206– cash tender offer $247m + 1CVR/share ANNOUNCED 2022-06-27
Micropep Technologies–CEA Industrie: investment, 202206 financing round Series A1 totalling €8.75m incl existing + co-investor Supernova Invest 2022-06-27
Micropep Technologies–Fall Line Capital: investment, 202206 financing round Series A1 totalling €8.75m incl new + lead investor Fall Line Capital 2022-06-27
Micropep Technologies–FMC: investment, 202206 financing round Series A1 totalling €8.75m incl existing + co-investor FMC Ventures 2022-06-27
Micropep Technologies–Irdi Soridec: investment, 202206 financing round Series A1 totalling €8.75m incl existing + co-investor Irdi/Soridec 2022-06-27
Micropep Technologies–SEVERAL: investment, 202206 financing round Series A1 €8.75m led by new investor Fall Line Capital 2022-06-27
Micropep Technologies–Sofinnova: investment, 202206 financing round Series A1 totalling €8.75m incl existing + co-investor Sofinnova Partners 2022-06-27
Kranus Health–Karista: investment, 202206 financing round Series A totalling >$6.5m incl lead investor Karista 2022-06-20
Kranus Health–SEVERAL: investment, 202206 financing round Series A >$6.5m led by Karista 2022-06-20
Valneva–Pfizer: investment, 202206 equity investment via capital increase €90.5m (representing 8.1% if capital) at €9.49/share 2022-06-20
ImCheck Therapeutics–Agent Capital: investment, 202206 financing round Series C totalling €80m incl existing + co-investor Agent Capital 2022-06-13
ImCheck Therapeutics–Alexandria Real Estate: investment, 202206 financing round Series C totalling €80m incl existing + co-investor Alexandria VI 2022-06-13
ImCheck Therapeutics–Andera Partners: investment, 202206 financing round Series C totalling €80m incl new + co-lead investor Andera Partners 2022-06-13
ImCheck Therapeutics–Bellevue: investment, 202206 financing round Series C totalling €80m incl existing + co-investor Pureos Bioventures 2022-06-13
ImCheck Therapeutics–Boehringer: investment, 202206 financing round Series C totalling €80m incl existing + co-investor BIVF 2022-06-13
ImCheck Therapeutics–Earlybird: investment, 202206 financing round Series C totalling €80m incl new + co-lead investor Earlybird 2022-06-13
ImCheck Therapeutics–EQT: investment, 202206 financing round Series C totalling €80m incl existing + co-investor EQT Life Sciences 2022-06-13
ImCheck Therapeutics–Eurazeo: investment, 202206 financing round Series C totalling €80m incl existing + co-investor Eurazeo 2022-06-13
ImCheck Therapeutics–Eurazeo: investment, 202206 financing round Series C totalling €80m incl existing + co-investor Kurma Partners GO Fund 2022-06-13
ImCheck Therapeutics–France (govt): investment, 202206 financing round Series C totalling €80m incl existing + co-investor Bpifrance Innobio 2 + LV 2022-06-13
ImCheck Therapeutics–Gimv: investment, 202206 financing round Series C totalling €80m incl existing + co-investor Gimv 2022-06-13
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21  next pagenext page



Advertisement

Picture University of Siena imss2023 Cagliari Sardinia Italy 650x100px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture EBD Group Biotech Showcase 2023 San Francisco 650x300px

» top